Acid inhibition and infections outside the gastrointestinal tract

American Journal of Gastroenterology

Volumn 104, Issue SUPPL. 2, 2009, Pages

  Vakil, Nimish ^a,b,c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b MARQUETTE UNIVERSITY   (United States)

^c AURORA SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; HISTAMINE H2 RECEPTOR ANTAGONIST; IMMUNOSUPPRESSIVE AGENT; PROTON PUMP INHIBITOR; RANITIDINE; SUCRALFATE;

ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; BACTERIAL COLONIZATION; BACTERIAL OVERGROWTH; BACTERIAL PNEUMONIA; CHRONIC LUNG DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL; COMMUNITY ACQUIRED PNEUMONIA; COMPETITIVE INHIBITION; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; ELDERLY CARE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL INFECTION; GASTROINTESTINAL TRACT; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HIGH RISK PATIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; LACTOBACILLUS; LUNG INFECTION; OROPHARYNX; PNEUMONIA; PRIORITY JOURNAL; RECURRENT INFECTION; REVIEW; STOMACH ACID; STREPTOCOCCUS; STRESS ULCER; VENTILATED PATIENT;

COMMUNITY-ACQUIRED INFECTIONS; GASTRIC ACID; GASTROESOPHAGEAL REFLUX; GRAM-NEGATIVE BACTERIAL INFECTIONS; HISTAMINE H2 ANTAGONISTS; HUMANS; OROPHARYNX; PNEUMONIA, BACTERIAL; PROTON PUMP INHIBITORS; RESPIRATION, ARTIFICIAL; RISK FACTORS; STOMACH;

EID: 61949340883     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.47     Document Type: Review

References (21)

1. Bateman DN, Colin-Jones D, Hartz S, et al., SURVEIL (Study of Undetected Reactions, Vigilance Enquiry into Links) Group. Mortality study of 18,000 patients treated with omeprazole. Gut 2003;52:942-6.
2. Raghunath A, O'Morain C, McLoughlin R. Review article: the long-term use of proton pump inhibitors. Aliment Pharmacol Ther 2005;22 (Suppl 1):55-61.
3. Leonard J, Marshall JK, Moayyedi P. Systematic review of the risk of enteric infection in patients taking acid suppression. Am J Gastroenterol 2007;102:2047-56.
4. Williams C, McColl K. Review article: proton pump inhibitors and bacterial overgrowth. Aliment Pharmacol Ther 2006;23:3-10.
5. Verdú EF, Bercík P, Armstrong D et al. Helicobacter pylori infection and omeprazole efficacy. Gastroenterology 1996;111:1401-2.
6. Cross A, Roup B. Role of respiratory assistance devices in endemic nosocomial pneumonia. Am J Med 1981;70:681-5.
7. Spray SB, Zuidema GD, Cameron JL. Aspiration pneumonia: incidence of aspiration with endotracheal tubes. Am J Surg 1976;131:701-3.
8. Ruddell WSJ, Axon AT, Findlay JM et al. Effect of cimetidine on gastric bacterial flora. Lancet 1980;1:672-4.
9. Torres A, El-Ebiary M, Solar N et al. Stomach as a source of colonization of the respiratory tract during mechanical ventilation: association with ventilator-associated pneumonia. Eur Respir J 1996;9:1729-35.
10. Cook D, Laine L, Guyatt G et al. Nosocomial pneumonia and the role of gastric pH. Chest 1991;100:7-13.
11. Tryba M. Sucralfate versus antacids or H2 antagonists for stress ulcer prophylaxis: a meta-analysis on efficacy and pneumonia rate. Crit Care Med 1991;19:942-9.
12. Cook D, Reeve B, Guyatt G et al. Stress ulcer prophylaxis in critically ill patients. JAMA 1996;275:308-14.
13. Cook D, Guyatt G, Marshall J, et al., the Canadian Critical Trials Group. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. New Engl J Med 1998;338:791-7.
14. Gardner TB, Robertson DJ. Stress ulcer prophylaxis in non-critically ill patients: less may be more. Am J Gastroenterol 2006;101:2206-8.
15. Liberman JD, Whelan CT. Brief report: reducing inappropriate usage of stress ulcer prophylaxis among internal medicine residents. A practice-based educational intervention. J Gen Intern Med 2006;21:498-500.
16. Laheij R, Sturkenboom M, Hassing RJ et al. Risk of community-acquired pneumonia and use of gastric acid-suppressive agents. JAMA 2004;292:1955-60.
17. Sataloff R. Community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA 2005;293:795-6.
18. Ruhl C, Sonnenberg A, Everhart J. Hospitalization with respiratory disease following hiatal hernia and reflux esophagitis in a prospective, population-based study. Ann Epidemiol 2001;11:477-83.
19. Gregor J. Acid suppression and pneumonia. JAMA 2004;292:2012-3.
20. Gulmez S, Holm A, Frederiksen H et al. Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study. Arch Intern Med 2007;167:950-5.
21. Canani R, Cirillo P, Roggero P et al. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community acquired pneumonia in children. Pediatrics 2006;117:817-20.